Norgine releases H1 2018 results

Back to media releases
Next media release
12 September 2018

Norgine releases H1 2018 results
 

  • Strong performance in the first half of 2018 reflects the continued growth of Norgine’s leading brands as well as product revenues acquired through the acquisition of Merus Labs International Inc. (“Merus”)

 

  • Merus integration complete

 

 

AMSTERDAM, The Netherlands. 12 September 2018. 08:00 AM CST.

 

Norgine generated sales of €196 million in the first half of 2018 (H1 2018), 28% higher than in H1 2017. This growth was driven by the established products added by the acquisition of Merus (+ €32 million sales) and growth of Norgine’s key promoted products – particularly MOVICOL® and XIFAXAN® (+ €11million vs. H1 2017).

 

Norgine continues to drive performance of its products in Europe, Australia and New Zealand where it is investing for future growth.

  • MOVICOL® – the market leading treatment for constipation grew strongly year-on-year with sales of €79.0 million in H1 2018, up 6% from H1 2017

 

  • MOVIPREP® – Norgine’s 2 litre bowel preparation for colonoscopy – achieved sales of €29.8 million in H1 2018, up 5% from H1 2017

 

  • PLENVU® – the first 1 litre bowel preparation for colonoscopy received FDA approval in May 2018 and was launched in the US in September 2018 It is available through Norgine’s infrastructure in Europe, Australia and New Zealand.

 

  • XIFAXAN® 550mg – for the treatment of hepatic encephalopathy – saw sales of €30 million in H1 2018, up 21% from H1 2017

 

  • LYMPHOSEEK® – a novel radiopharmaceutical used in sentinel lymph node biopsy (SLNB), in adult patients with breast cancer, melanoma, or localised squamous cell carcinoma of the oral cavity. LYMPHOSEEK® was launched in additional markets across Europe. It is available in Denmark, the Netherlands, the UK, Germany and Spain.

 

 

 

 

Significant key business developments

  • Following the acquisition of Merus in July 2017, the integration is now complete
  • Norgine continues its growth strategy and moved to a new office in Wettenberg, Germany. Germany is Norgine’s largest market.

 

Peter Stein, CEO at Norgine said: “Our performance during the first half of 2018 demonstrates that our strategy is working. We are continuing to bring transformative products to market for the benefit of patients. The established products acquired through Merus and our promoted products, in particular MOVICOL® and XIFAXAN®, are key growth drivers for us. With the addition of PLENVU® to our product portfolio, we anticipate further growth in the remainder of 2018 and into 2019. Our success is a reflection of the hard work of our “One Norgine” team which has built a strong platform through which we can attract new opportunities for the benefit of patients.”

Ends

Notes to Editors:

About Norgine

 

Norgine is a leading European specialist pharmaceutical company with a direct commercial presence in all major European markets. In 2017, Norgine’s total net product sales were EUR 345 million, up 17 per cent.

Norgine employs over 1,000 people across its commercial, development and manufacturing operations and manages all aspects of product development, production, marketing, sale and supply.

Norgine specialises in gastroenterology, hepatology, cancer and supportive care.

 

Norgine is headquartered in the Netherlands.

 

For more information, please visit www.norgine.com

In 2012, Norgine established a complementary business Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.

NORGINE and the sail logo are trademarks of the Norgine group of companies.

 

Media Contacts:

Isabelle Jouin, T: +44 (0)1895 826237

Follow us @norgine

 

 

 

Norgine Australia
Cookie Policy

Last update: 1 August 2023

 

What are cookies?

Cookies are small data files that websites download to a user’s computer, phone or tablet. Most web browsers automatically accept cookies. They help website providers, for example, to recognise a user that has visited a website previously. Further details on the cookies used on this Website and their purposes are set out below.

 

  • Helping you navigate the Website in the most easy way possible
  • Assisting in registering for our events, login and your ability to provide feedback
  • Analysing site usage (how many users visited a specific page for example)
  • Analysing the use of our products, services or applications
  • Assisting with our promotional and marketing efforts (including behavioural advertising)
  • Offering content of third parties (such as social media content)

 

Detailed information about each cookie can be found in the appropriate cookie category section of the banner as well as in the section below.

Cookie Category Description

STRICTLY NECESSARY COOKIES

The strictly necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You may be able to decline these cookies through your browser, but necessary parts of the site will not then work. These cookies do not store any personally identifiable information.

 

Detailed list of Strictly Necessary Cookies

First- and Third-party Cookies Name Provider Purpose Retention
Third Party moove_gdpr_popup mooveagency.com Records cookie settings. For user preferences only. No external interaction 1 year

 

FUNCTIONAL COOKIES

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

 

Detailed list of Functional Cookies

First- and Third-party Cookies Name Provider Purpose Retention
Not applicable        

 

PERFORMANCE COOKIES

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.

 

Detailed list of Performance Cookies

First- and Third-party Cookies Name Provider Purpose Retention
Third Party _ga_ google.com Record visitors cookie choice. 400 days
Third Party _gat_gtag_ google.com Records tracking code data 1 minute
Third Party _ga google.com Calculates visitor, session and campaign data and also keeps track of site usage. 400 days
Third Party _gid google.com Registers a unique ID that is used to generate statistical data on how the visitor uses the website. 1 day

 

MARKETING COOKIES

These cookies are used to track our visitors’ browsing habits. They can be used to build up a profile of search and/or browsing history for every visitor. Identifiable or unique data is collected to show relevant/personalized marketing content to each user. The information that uniquely identifies users’ browsers and internet devices is used to display targeted advertising and/or share this data with third parties for the same purpose.

 

Detailed list of Marketing Cookies

First- and Third-party Cookies Name Provider Purpose Retention
Not applicable        

 

Refusing cookies

You do not have to accept cookies, but without accepting them you may experience reduced Site functionality. You can manage your preferences regarding cookies and other tracking technologies and revoke your consent in the banner. You can withdraw your consent at any time. If you would like more information about deleting, disabling and blocking cookies, please visit the website: https://knowcookies.com and check the “manage cookies” and “webmasters guide” sections.

 

Updating our Cookie Policy

There is a possibility that we will update our cookie policy on this website in accordance with legal and technical requirements, therefore we recommend that you read this policy occasionally so that you are adequately informed about how and for what we use cookies.

 

Contact

If you have any questions about this Cookie Policy or the collection, processing and disclosure of your personal data and your data protection rights, please see our Privacy Policy.